ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
34.75
-1.29 (-3.58%)
Mar 20, 2026, 3:00 PM CST

ChengDu ShengNuo Biotec Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
50.0270.3464.4861.25
Depreciation & Amortization
34.5627.6524.6918.26
Other Amortization
1.191.491.270.49
Loss (Gain) From Sale of Assets
0.590.910.394.89
Loss (Gain) From Sale of Investments
-1.871.42-2.48-1.51
Provision & Write-off of Bad Debts
8.363.082.460.86
Other Operating Activities
20.6913.656.332.52
Change in Accounts Receivable
-49.969.82-22.22-17.6
Change in Inventory
-120.11-63.79-38.72-12.54
Change in Accounts Payable
83.0418.6457.6-5.28
Change in Other Net Operating Assets
4.212.851.121.11
Operating Cash Flow
25.2784.7895.6252.41
Operating Cash Flow Growth
-70.19%-11.34%82.44%-35.17%
Capital Expenditures
-247.48-277.98-135.85-64.22
Sale of Property, Plant & Equipment
0.050.330.130.11
Investment in Securities
13.45-93.4152.3-209.9
Other Investing Activities
3.151.754.38-7.9
Investing Cash Flow
-230.83-369.3120.96-281.91
Long-Term Debt Issued
302.58216.710030
Total Debt Issued
302.58216.710030
Long-Term Debt Repaid
-82.29-57.94-30.93-1.93
Total Debt Repaid
-82.29-57.94-30.93-1.93
Net Debt Issued (Repaid)
220.29158.7569.0728.07
Issuance of Common Stock
6.58--310
Common Dividends Paid
-34.17-29.18-26.82-0.03
Other Financing Activities
-0.20.18--25.85
Financing Cash Flow
192.51129.7542.25312.2
Foreign Exchange Rate Adjustments
0.680.53-0.67
Net Cash Flow
-12.37-154.27161.8382.04
Free Cash Flow
-222.2-193.2-40.23-11.81
Free Cash Flow Margin
-48.72%-44.41%-10.17%-3.06%
Free Cash Flow Per Share
-1.40-1.22-0.26-0.08
Cash Income Tax Paid
29.957.4217.5434.69
Levered Free Cash Flow
-239.08-252.24-83.39-50.55
Unlevered Free Cash Flow
-231.71-246.57-81.36-50.45
Change in Working Capital
-88.27-33.75-1.52-34.35
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.